Cancer Control

RTOG R0614    Consent    HIPAA    Protocol    (closed 07/21/10)

A Randomized, Phase III, Double-blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiotherapy

RTOG R0517     Consent    HIPAA   Protocol                                                                                                                                Pre-registration requirements (see protocol section 5.0)

Randomized Phase III trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast and Prostate Cancer

RTOG R0831   Consent  QOL Consent  HIPAA    Protocol   (temporary closure)

A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated With Radiotherapy for Prostate Cancer 

BRAIN

RTOG R0825    Consent     HIPAA    Protocol   

Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly-Diagnosed Glioblastoma

CTSU E3F05    Consent    HIPAA     Protocol    

Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas

RTOG R0539  Consent    HIPAA     Protocol   

Phase II Trial of Observation for Low-Risk Meningiomas and of Radiotherapy for Intermediate- and High-Risk

NCCTG N057K   Consent   HIPAA    Protocol  

Phase I/II Evaluation of Everolimus (RAD001), Radiation and Temozolomide (TMZ) Followed by Adjuvant Temozolomide and Everolimus in Newly Diagnosed Glioblastoma

       Brain Mets

NCCTG N0574  Consent   HIPAA    Protocol

Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients with One to Three Cerebral Metastases

BREAST

NSABP B-39        Consent    HIPAA    Fast Facts     Protocol    (Closed to specific patients)

A Randomized Phase III Study of Conventional Whole Breast Irradiation versus Partial Breast Irradiation for Women with Stage 0, I or II Breast Cancer

     Breast - Metastatic

RTOG R0517     Consent    HIPAA   Protocol                                                                                                                     Pre-registration requirements (see section 5.0 of the protocol)

Randomized Phase III trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast and Prostate Cancer

GASTROINTESTINAL

  Colon - Rectal  

      Rectal

NSABP R-04    Consent    HIPAA     Fast Facts     Protocol

A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with Preoperative Radiation Therapy and Continuous Intravenous Infusion of 5-Fluorouracil in the Treatment of Patients with Operable Carcinoma of the Rectum

    Stomach

    Esophageal

RTOG R0436    Consent   HIPAA   Protocol   Treatment Calendar Arm 1    Arm 2

A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery

    Pancreas

RTOG R0848  Consent  HIPAA  Protocol Treatment Calendar Arm 1 Arm 2  Arm 3(1)   Arm 3(2)  Arm 4(1)  Arm 4(2)

A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

    Gallbladder

GENITOURINARY

    Prostate

CTSU MDA-3410    Consent    HIPAA    Fast Facts     Protocol  

A Prospective Randomized Phase II Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer

RTOG R0517     Consent    HIPAA   Protocol                                                                                                                                Pre-registration requirements (see section 5.0 of the protocol)

Randomized Phase III trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast and Prostate Cancer

RTOG R0534  Consent     HIPAA     Protocol  

A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy

RTOG R0622     Consent     HIPAA     Protocol   

A Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy

RTOG R0815   Consent   HIPAA    Protocol   

A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer

   Bladder/Urothelium

RTOG R0524    Consent    HIPAA    Protocol  

A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Tranurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer

      Germ Cell Malignancies

    Renal

GYNECOLOGIC

     Ovarian

     Cervical

    Endometrial

HEAD & NECK

RTOG R0920   Consent   HIPAA    Protocol

 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

LEUKEMIA

    Acute Leukemia

    Chronic Leukemia

LUNG 

Non-Small Cell      

CTSU C30610   Consent    HIPAA       Protocol    Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide

RTOG R0517     Consent    HIPAA   Protocol                                                                                                                                Pre-registration requirements (see section 5.0 of the protocol)

Randomized Phase III trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast and Prostate Cancer

RTOG R0617     Consent     HIPAA     Protocol 

A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer

RTOG R0915   Consent   HIPAA     Protocol  

A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer

      Small Cell

RTOG R0937        Consent    HIPAA    Protocol 

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative  Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED_SCLC)

LYMPHOMA

    Hodgkin's

   Non-Hodgkin's

    Mantle Cell

Melanoma                                                       

Myeloma

Sarcoma 

Other   

RTOG R0631   Consent    HIPAA    Protocol 

Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis

Return to the Top